BIOMAT Database Logo BIOMAT Database Logo

Chimeric antigen receptor T (CAR-T) cells expanded with IL-7/IL-15 mediate superior antitumor effects. 2019

Jianxia Zhou, and Liyuan Jin, and Fuping Wang, and Yuan Zhang, and Bing Liu, and Tongbiao Zhao
State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, 100101, China.

UI MeSH Term Description Entries
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000076962 Receptors, Chimeric Antigen Synthetic cellular receptors that reprogram T-LYMPHOCYTES to selectively bind antigens. Chimeric Antigen Receptor,Chimeric T-Cell Receptor,Artificial T-Cell Receptors,Chimeric Antigen Receptors,Chimeric Immunoreceptors,Chimeric T-Cell Receptors,Antigen Receptor, Chimeric,Antigen Receptors, Chimeric,Artificial T Cell Receptors,Chimeric T Cell Receptor,Chimeric T Cell Receptors,Immunoreceptors, Chimeric,Receptor, Chimeric Antigen,Receptor, Chimeric T-Cell,Receptors, Artificial T-Cell,Receptors, Chimeric T-Cell,T-Cell Receptor, Chimeric,T-Cell Receptors, Artificial,T-Cell Receptors, Chimeric
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D015851 Interleukin-7 A cytokine produced by bone marrow stromal cells that promotes the growth of B-LYMPHOCYTE precursors and is co-mitogenic with INTERLEUKIN-2 for mature T-LYMPHOCYTE activation. IL-7,IL7,Lymphopoietin-1,Interleukin 7,Lymphopoietin 1
D016219 Immunotherapy, Adoptive Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314) Adoptive Cellular Immunotherapy,Adoptive Immunotherapy,CAR T-Cell Therapy,Cellular Immunotherapy, Adoptive,Chimeric Antigen Receptor Therapy,Immunotherapy, Adoptive Cellular,Adoptive Cellular Immunotherapies,Adoptive Immunotherapies,CAR T Cell Therapy,CAR T-Cell Therapies,Cellular Immunotherapies, Adoptive,Immunotherapies, Adoptive,Immunotherapies, Adoptive Cellular,T-Cell Therapies, CAR,T-Cell Therapy, CAR,Therapies, CAR T-Cell,Therapy, CAR T-Cell
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D018920 Coculture Techniques A technique of culturing mixed cell types in vitro to allow their synergistic or antagonistic interactions, such as on CELL DIFFERENTIATION or APOPTOSIS. Coculture can be of different types of cells, tissues, or organs from normal or disease states. Cocultivation,Co-culture,Coculture,Co culture,Co-cultures,Cocultivations,Coculture Technique,Cocultures

Related Publications

Jianxia Zhou, and Liyuan Jin, and Fuping Wang, and Yuan Zhang, and Bing Liu, and Tongbiao Zhao
Humanized Chimeric Antigen Receptor (CAR) T cells.
January 2021, Journal of cancer immunology,
Jianxia Zhou, and Liyuan Jin, and Fuping Wang, and Yuan Zhang, and Bing Liu, and Tongbiao Zhao
Chimeric Antigen Receptor beyond CAR-T Cells.
January 2021, Cancers,
Jianxia Zhou, and Liyuan Jin, and Fuping Wang, and Yuan Zhang, and Bing Liu, and Tongbiao Zhao
Glioblastoma-targeted CD4+ CAR T cells mediate superior antitumor activity.
May 2018, JCI insight,
Jianxia Zhou, and Liyuan Jin, and Fuping Wang, and Yuan Zhang, and Bing Liu, and Tongbiao Zhao
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T).
January 2021, Mediterranean journal of hematology and infectious diseases,
Jianxia Zhou, and Liyuan Jin, and Fuping Wang, and Yuan Zhang, and Bing Liu, and Tongbiao Zhao
Chimeric NK-receptor-bearing T cells mediate antitumor immunotherapy.
September 2005, Blood,
Jianxia Zhou, and Liyuan Jin, and Fuping Wang, and Yuan Zhang, and Bing Liu, and Tongbiao Zhao
Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells.
March 2019, International journal of molecular sciences,
Jianxia Zhou, and Liyuan Jin, and Fuping Wang, and Yuan Zhang, and Bing Liu, and Tongbiao Zhao
Chimeric Antigen Receptor (CAR) T-Cell Therapy.
November 2017, JAMA oncology,
Jianxia Zhou, and Liyuan Jin, and Fuping Wang, and Yuan Zhang, and Bing Liu, and Tongbiao Zhao
Chimeric antigen receptor (CAR)-T cell therapy.
February 2017, Nihon rinsho. Japanese journal of clinical medicine,
Jianxia Zhou, and Liyuan Jin, and Fuping Wang, and Yuan Zhang, and Bing Liu, and Tongbiao Zhao
Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T).
December 2019, Journal of the American College of Cardiology,
Jianxia Zhou, and Liyuan Jin, and Fuping Wang, and Yuan Zhang, and Bing Liu, and Tongbiao Zhao
[CAR-T cells: Lymphocytes that express a chimeric antigen receptor].
August 2019, La Revue de medecine interne,
Copied contents to your clipboard!